SynGen Inc.

Patent Applications and Registrations

Patent applications and USPTO patent grants for SynGen Inc..The latest application filed is for "method of preparing an osteogenic bone graft".

Company Profile

0.10.16

SynGen Inc. - Sacramento CA US
Syngen, Inc. - Hayward CA
SYNGEN, INC. -
SYNGEN, INC. - San Carlos CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks

Patent Activity

Patent	Date
Method and apparatus for cryopreservation of blood cells in a sterile environment Grant 10,045,526 - Coelho August 14, 2	2018-08-14
Method Of Preparing An Osteogenic Bone Graft App 20180221539 - LEHMICKE; Michael ; et al.	2018-08-09
Cell Separation Devices, Systems, and Methods App 20170349875 - Coelho; Philip H. ; et al.	2017-12-07
Cell separation devices, systems, and methods Grant 9,821,111 - Coelho , et al. November 21, 2	2017-11-21
Cell Separation Devices, Systems, and Methods App 20170224904 - Coelho; Philip H. ; et al.	2017-08-10
Process for Isolating a Purified Cell Population Isolated from Whole Blood App 20170199106 - Coelho; Philip H.	2017-07-13
Cell separation devices, systems, and methods Grant 9,695,394 - Coelho , et al. July 4, 2	2017-07-04
Cell Separation Devices, Systems, and Methods App 20170183619 - Coelho; Philip H. ; et al.	2017-06-29
Method for purifying certain cell populations in blood or bone marrow by depleting others Grant 9,599,545 - Coelho March 21, 2	2017-03-21
Method And Apparatus For Cryopreservation Of Blood Cells In A Sterile Environment App 20160219869 - Coelho; Philip H.	2016-08-04
Method for Purifying Certain Cell Populations in Blood or Bone marrow by Depleting Others App 20140212914 - Coelho; Philip H.	2014-07-31
Purified Cell Population Isolated from Whole Blood App 20140212912 - Coelho; Philip H.	2014-07-31
System for purifying certain cell populations in blood or bone marrow by depleting others Grant 8,747,289 - Coelho June 10, 2	2014-06-10
System for Purifying Certain Cell Populations in Blood or Bone Marrow by Depleting Others App 20130029370 - Coelho; Philip H.	2013-01-31
Compositions and methods for the use of FMOC derivatives in DNA/RNA synthesis Grant 7,667,033 - Alvarado February 23, 2	2010-02-23
Compositions And Methods For The Use Of Fmoc Derivatives In Dna/rna Synthesis App 20090171076 - Alvarado; Gabriel	2009-07-02
Compositions and methods for the use of FMOC derivatives in DNA/RNA synthesis Grant 7,534,872 - Alvarado May 19, 2	2009-05-19
Compositions and methods for the use of FMOC derivatives in DNA/RNA synthesis App 20070179289 - Alvarado; Gabriel	2007-08-02
Compositions and methods for labeling oligonucleotides App 20040234957 - Chiarello, Ronald H. ; et al.	2004-11-25
Compositions and methods for the use of FMOC derivatives in DNA/RNA synthesis App 20040180355 - Alvarado, Gabriel	2004-09-16
Rhodamine-based fluorophores useful as labeling reagents Grant 6,750,357 - Chiarello , et al. June 15, 2	2004-06-15
Compositions and methods for labeling oligonucleotides App 20030104380 - Chiarello, Ronald H. ; et al.	2003-06-05

Company Registrations

NCAGE Code	76VN1	SYNGEN INC.
CAGE Code	76VN1	SYNGEN INC.
SEC	0001547876	SynGen Inc. of DELAWARE

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.